Small Molecule APIs Manufacturing
|
SAFC Manchester, UK
 cGMP scale up for early stage development,
medicinal chemistry
Overview - cGMP Manufacturing Facility
Manchester Facility Insert - 332 KB pdf
Quality Managmement & Contact |
|
 |
|
SAFC Gillingham, UK
cGMP APIs, complex multi-step synthesis
Overview - cGMP Manufacturing Facility
Gillingham Facility Insert - 326 KB pdf
Quality Managmement & Contact |
|
 |
|
SAFC Buchs, Switzerland
cGMP APIs, complex multi-step synthesis
Overview - cGMP Manufacturing Facility
Buchs, Facility Insert - 332 KB pdf
Quality Managmement & Contact |
|
 |
|
SAFC Madison, WI, USA
High-Potent APIs (HPAPIs)
Visit our facility
Overview - cGMP Manufacturing Facility
Madison Facility Insert - 319 KB pdf
Quality Managmement & Contact |
|
 |
|
SAFC Arklow, Ireland
Commercial scale APIs
Overview - cGMP Manufacturing Facility
Arklow Facility Insert - 328 KB pdf
Quality Managmement & Contact |
|
 |
| |
Key Intermediates
|
SAFC Bangalore, India
Pre-clinical development specialized in medicinal chemistry
Overview - ISO certified Manufacturing facility |
|
 |
|
SAFC Steinheim, Germany
Multi-step synthesis of key intermediates
Quality Managmement & Contact |
|
 |
|
SAFC Sheboygan, WI, USA
Multi-step synthesis of key intermediates
Overview - cGMP Manufacturing Facility
Quality Managmement & Contact |
|
 |
|
SAFC Wushi, China
Multi-step synthesis of raw materials and key intermediates for late 2009
Coming Soon... |
|
 |
| |
Biologic Drug Products
|
SAFC St. Louis, MO, USA
 Large-scale natural and recombinant proteins, potent and non-potent bio-conjugation
St. Louis Facility Insert - 319 KB pdf
Overview - cGMP Manufacturing Facility
Quality Managmement & Contact |
|
 |
|
SAFC Carlsbad, CA, USA
Viral vectors and vaccine manufacturing, novel excipients and adjuvants
Overview - cGMP Manufacturing Facility
Carlsbad Facility Insert - 316 KB pdf |
|
 |
|
SAFC Jerusalem, Israel
Fermentation derived drug products
Jerusalem Facility Insert - 285 KB pdf
Fermentation Details Insert - 227 KB pdf
Quality Managmement & Contact
|
|
 |
| |
